What's new? Log in Free sign up

Filing search / Fusion Pharmaceuticals Inc / "Materials"

Search information

Fusion Pharmaceuticals Inc

Companies

"Materials"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

84 results

Newest first Best match first

FUSN Fusion Pharmaceuticals Inc

Additional proxy soliciting materials

Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2) Definitive Proxy Statement Definitive Additional Materials … materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

FUSN Fusion Pharmaceuticals Inc

materials in connection with the transaction with the SEC and the CSA. Shareholders are urged to read the management information circular and proxy … statement and/or consent solicitation documents regarding the transaction and any other relevant materials carefully in their entirety before making any

FUSN Fusion Pharmaceuticals Inc

Quarterly report

and information related to an unspecified target, including governmental authorizations, regulatory materials, books and records, patents, third party claims … million at lease commencement in February 2022. From time to time, the Company enters into arrangements with CDMOs for the manufacture of materials

7 May 24

8:00am

FUSN Fusion Pharmaceuticals Inc

Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates

a management information circular and proxy statement on April 25, 2024. Additionally, Fusion will file other relevant materials in connection … solicitation documents regarding the transaction and any other relevant materials carefully in their entirety when they become available before making

FUSN Fusion Pharmaceuticals Inc

Additional proxy soliciting materials

a preliminary management information circular and proxy statement on April 10, 2022. Additionally, Fusion will file other relevant materials … and/or consent solicitation documents regarding the transaction and any other relevant materials carefully in their entirety when they become available before

torgbshf4u03ksyyxvik

Proxy related to merger

Additional proxy soliciting materials

biqdkhlm1x 24f175s2

Annual report (amended)

12 Apr 24

8:00am

Preliminary proxy related to merger

20 Mar 24

4:14pm

20 Mar 24

4:14pm

Additional proxy materials by non-management

2o7o to2x3mpetcal

Additional proxy soliciting materials

Voting and Support Agreement

Voting and Support Agreement

Voting and Support Agreement

Voting and Support Agreement

Entry into a Material Definitive Agreement

Prev
1
2
3
4
5
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.